However, this has not been shown in humans," says Tishler
These compounds are not approved by the U.S Food and Drug Administration (FDA) for weight loss, but healthcare providers prescribe these compounds off-label for weight loss and improving metabolic health
Providers can best support lasting outcomes through structured weight-maintenance programs and continuous patient support long after semaglutide use concludes
This weight loss isnt merely cosmetic
Additionally, the company may find a market among patients who cannot take the full dose of semaglutide, building upon the trend of microdosing the medications
Joint Pain and Mobility Excess weight stresses joints, particularly weight-bearing joints: Knee pain: Often improves substantially with weight loss, as mechanical load decreases